Bupivacaine + Midazolam

The combination of bupivacaine and midazolam is used primarily for spinal anesthesia and regional nerve blocks. This combination has been studied for its synergistic effects in providing improved analgesia and prolonged duration of action compared to bupivacaine alone. Bupivacaine is an amide local anesthetic that works by blocking sodium channels, preventing nerve impulse generation and conduction. Midazolam is a benzodiazepine that has been found to have antinociceptive properties when administered intrathecally, enhancing the analgesic effects of local anesthetics. Clinical studies have shown that when midazolam is added to bupivacaine for spinal anesthesia, it significantly improves the duration and quality of sensory and motor blockade while providing prolonged postoperative analgesia. For example, one study found that adding 2 mg of intrathecal midazolam to bupivacaine and buprenorphine extended postoperative analgesia from approximately 9 hours to 21 hours[1]. Another study demonstrated that adding 1 mg of midazolam to bupivacaine for spinal anesthesia prolonged sensory block duration from 165 minutes to 218 minutes[6]. The combination has been used in various procedures including lower abdominal surgery, orthopedic procedures, and brachial plexus blocks. Research indicates that the addition of midazolam not only extends the duration of analgesia but also improves the quality of the nerve block with minimal side effects[4][6]. This combination represents an effective approach to improving perioperative pain management while potentially reducing the need for additional analgesics postoperatively.

Other names

midazolam and bupivacainemidazolam-bupivacaine combination